Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Vaccines|November 26, 2025
T-Cell-Based Universal Dengue Vaccine Design for Robust Protective ResponseYi Fei Sun, Adeline Yeo Syin Lian, Meng Ling MoiPathogens (Basel, Switzerland)|May 27, 2026
Functional Antibody-Dependent Enhancement as an Immune Assessment Platform: Development, Standardization, and Translational Interpretation in Flavivirus ResearchMeng Ling MoiUirusu|May 8, 2022
[Dengue amidst COVID-19: challenges & control measures for the double burden]Meng Ling MoiRinsho Byori. the Japanese Journal of Clinical Pathology|January 5, 2019
[Dengue Fever]Meng Ling Moi, Tomohiko TakasakiMethods in Molecular Biology (Clifton, N.J.)|May 29, 2016
Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence AssayMeng Ling Moi, Tomohiko TakasakiPathogens (Basel, Switzerland)|October 23, 2021
Complexities in Case Definition of SARS-CoV-2 Reinfection: Clinical Evidence and Implications in COVID-19 Surveillance and DiagnosisLisa Yamasaki, Meng Ling MoiTropical Medicine and Health|July 12, 2016
Human antibody response to dengue virus: implications for dengue vaccine designMeng Ling Moi, Tomohiko Takasaki, Ichiro KuraneMethods in Molecular Biology (Clifton, N.J.)|October 8, 2017
Detection of Virus-Antibody Immune Complexes in Secondary Dengue Virus InfectionMeng Ling Moi, Tomohiko Takasaki, Ichiro KuranePlants (Basel, Switzerland)|October 14, 2022
Novel Antiviral Efficacy of Hedyotis diffusa and Artemisia capillaris Extracts against Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Infection and Immunoregulatory Cytokine SignaturesZhan Qiu Mao, Noboru Minakawa, Meng Ling MoiArchives of Virology|August 1, 2013
Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcγR-expressing BHK cellsMeng Ling Moi, Tomohiko Takasaki, Masayuki Saijo, et al.Pageof 17